CURRENT
ISSUE
1740

Influenza is generally a self-limited illness, but complications including pneumonia, respiratory failure, and death can occur, especially in persons at increased risk (see Table 1).

TREATMENT OF INFLUENZA — Three neuraminidase inhibitors (oral oseltamivir, IV peramivir, and inhaled zanamivir) and the oral cap-dependent endonuclease inhibitor baloxavir marboxil are available in the US and are recommended for treatment of influenza this season (see Table 2).1

Antiviral...  Continue reading

Coming Soon
Aceclidine (Vizz) for Presbyopia
Sulopenem Etzadroxil/Probenecid (Orlynvah) for Uncomplicated UTIs
Garadacimab (Andembry) for Hereditary Angioedema Prophylaxis
In Brief: Additional MRI Monitoring with Lecanemab (Leqembi)